UTHealth School of Dentistry

Chrysalis BioTherapeutics Selected to Present at Respiratory Innovation Summit

Retrieved on: 
星期一, 五月 6, 2024
Biotechnology, FDA, Health, Pharmaceutical, Other Science, Research, Infectious Diseases, Hospitals, Science, COVID-19, Clinical Trials, University, Pupa, Summit, COVID, UTHealth School of Dentistry, NIH, Abstract, Human services, UTMB, Development, TBI, Therapy, Patient, RIS, Diagnosis, White lung, American Thoracic Society

Chrysalis BioTherapeutics today announced it was selected to participate in the 2024 Respiratory Innovation Summit (RIS) at the American Thoracic Society Meeting in San Diego.

Key Points: 
  • Chrysalis BioTherapeutics today announced it was selected to participate in the 2024 Respiratory Innovation Summit (RIS) at the American Thoracic Society Meeting in San Diego.
  • This year, Chrysalis was selected as one of six “Critical Care Therapeutic Innovator” companies for oral presentation at the Summit.
  • “To be selected to present at the Respiratory Summit is a great honor for Chrysalis and confirms that experts in this field recognize the potential of TP508 (Chrysalin™) to prevent progression of acute lung injury,” said Dr. Darrell Carney, Chrysalis CEO.
  • Chrysalis BioTherapeutics is currently seeking investors and pharma partners for pulmonary and other indications including TBI, radiation therapy and mitigation chronic pulmonary diseases.

UTMB Health Selects Tendo's Data and Analytics Software

Retrieved on: 
星期一, 四月 8, 2024
UTHealth School of Dentistry, Health, Documentation, CDI, Caregiver, UTMB, Patient, Hospital, University, QDI, Tendō, Nursing

PHILADELPHIA, April 8, 2024 /PRNewswire/ -- Tendo, a software company creating seamless healthcare experiences for patients, clinicians, and caregivers while improving quality, financial, health, and operations outcomes, announces its newest customer, the University of Texas Medical Branch (UTMB Health).

Key Points: 
  • PHILADELPHIA, April 8, 2024 /PRNewswire/ -- Tendo, a software company creating seamless healthcare experiences for patients, clinicians, and caregivers while improving quality, financial, health, and operations outcomes, announces its newest customer, the University of Texas Medical Branch (UTMB Health).
  • Located in Galveston, TX, UTMB Health is a major academic health sciences center of global influence, a world-renowned research enterprise, and a growing, comprehensive health system with hospitals on four campuses and a network of clinics.
  • "UTMB Health already delivers quality clinical care.
  • Tendo's quality suite uses advanced analytics and AI to quickly and accurately identify opportunities for clinical documentation improvement while streamlining clinical workflows and simplifying clinician activities.

Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting

Retrieved on: 
星期四, 二月 29, 2024
UTHealth School of Dentistry, Division, Toxicity, Wound healing, ID, RBS, Society, Doctor of Philosophy, Safety, University, Control, Assistant professor, Surgery

KNOXVILLE, TN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that data from ongoing preclinical research on the topical administration of a formulation of Provectus’s proprietary, pharmaceutical-grade, small molecule, rose bengal sodium (“RBS”) drug substance are being presented at the annual meeting of the Society for Investigative Dermatology (“SID”), to be held May 15-18, 2024 in Dallas, Texas.

Key Points: 
  • KNOXVILLE, TN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that data from ongoing preclinical research on the topical administration of a formulation of Provectus’s proprietary, pharmaceutical-grade, small molecule, rose bengal sodium (“RBS”) drug substance are being presented at the annual meeting of the Society for Investigative Dermatology (“SID”), to be held May 15-18, 2024 in Dallas, Texas.
  • The accepted SID abstract is titled “Assessing the safety and toxicity of multi-dosed topical Rose Bengal Sodium (RBS) in a murine model of full-thickness cutaneous injury” (Control ID 4074036, Final ID 813, Current Category: Translational Studies and Early Preclinical to Clinical).
  • The work underlying this poster presentation is part of an ongoing sponsored research program with Amina El Ayadi, Ph.D., Assistant Professor, Division of Surgical Sciences, Department of Surgery at the University of Texas Medical Branch at Galveston to characterize the effects of RBS on full-thickness cutaneous wounds and during the subsequent phases of wound healing.

Viz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage

Retrieved on: 
星期四, 二月 8, 2024
Technology, Hospitals, FDA, Health Technology, Cardiology, Software, Practice Management, Health, Data Management, Artificial Intelligence, Radiology, Viz, Neurology, Brain, FRCSC, NCCT, Food, Food and Drug Administration, ICH, AI, University, UTHealth School of Dentistry, MPH, Multimedia, Neurosurgery, Hospital, Stroke, Lateral ventricles, Disease, Intracerebral hemorrhage

“This technology, which marries precision with AI, is poised to transform how we approach intracerebral hemorrhage cases."

Key Points: 
  • “This technology, which marries precision with AI, is poised to transform how we approach intracerebral hemorrhage cases."
  • Intracerebral hemorrhage accounts for up to 15% of all strokes and has high morbidity and mortality rates, demanding swift response.
  • Accurate volume measurements of brain bleeds are crucial for assessing the severity of cases, monitoring progression, and planning treatment strategies.
  • Viz ICH Plus exemplifies our dedication to enhancing patient care by leveraging technology," stated Jayme Strauss, chief clinical officer at Viz.ai.

SightMD Pennsylvania Welcomes David L. Silverman, MD to its Expert Team

Retrieved on: 
星期一, 二月 5, 2024
Greater Baltimore Medical Center, History, Fear, Language, MD, Teaching, Ageing, Patient, American Academy, Love, Microsurgery, Disease, UTHealth School of Dentistry, Eastern Virginia Medical School, Health, Medicine, University, Eye, Internal medicine, Private practice

HAUPPAUGE, N.Y., Feb. 5, 2024 /PRNewswire-PRWeb/ -- SightMD PA, a leading multi-specialty ophthalmology platform in Pennsylvania, welcomes David L. Silverman, MD to its expert team.

Key Points: 
  • SightMD PA, a leading multi-specialty ophthalmology platform in Pennsylvania, welcomes David L. Silverman, MD to its expert team.
  • HAUPPAUGE, N.Y., Feb. 5, 2024 /PRNewswire-PRWeb/ -- SightMD PA, a leading multi-specialty ophthalmology platform in Pennsylvania, welcomes David L. Silverman, MD to its expert team.
  • David L. Silverman, MD has been practicing comprehensive ophthalmology for nearly 30 years.
  • He is board certified by the American Board of Ophthalmology and is an active fellow of the American Academy of Ophthalmology.

Northrop Grumman’s 20th Cargo Resupply Mission Successfully Launches to the International Space Station for NASA

Retrieved on: 
星期二, 一月 30, 2024
Cygnus, Science, International Space Station, Space medicine, ISS, Injury, NOC, Spacecraft, UTHealth School of Dentistry, Death, Grumman, University, NASA, Communications satellite

CAPE CANAVERAL, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation’s (NYSE: NOC) Cygnus cargo delivery spacecraft was successfully launched to the International Space Station today by SpaceX’s Falcon 9 rocket from Space Launch Complex 40 at Cape Canaveral Space Force Station in Florida.

Key Points: 
  • CAPE CANAVERAL, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation’s (NYSE: NOC) Cygnus cargo delivery spacecraft was successfully launched to the International Space Station today by SpaceX’s Falcon 9 rocket from Space Launch Complex 40 at Cape Canaveral Space Force Station in Florida.
  • Northrop Grumman’s Cygnus spacecraft for the NG-20 cargo delivery mission to the International Space Station launched from Cape Canaveral Space Force Station in Florida.
  • After its rendezvous with the International Space Station on February 1, Cygnus will remain attached to the station for up to six months.
  • Northrop Grumman’s Cygnus provides the only U.S. spacecraft reboost capability for the International Space Station.

Caring Transitions Brings Compassionate Care to Boerne, Texas

Retrieved on: 
星期一, 一月 22, 2024
Family, Fair Oaks Ranch, Texas, Texas A&M University, Science, University, Love, UTHealth School of Dentistry, Integrity, Parent, Sales management, Nursing

BOERNE, Texas, Jan. 22, 2024 /PRNewswire-PRWeb/ -- Caring Transitions is the nation's largest and most trusted organization specializing in senior relocation, downsizing, and estate sales. The latest location, Caring Transitions of Boerne, Fredericksburg and Kerrville, expands the network in the state of Texas. Caring Transitions of Boerne, Fredericksburg and Kerrville is owned and operated by Dershie Kurtz and will look to serve Boerne, Fair Oaks Ranch, Fredericksburg, Kerrville, and the surrounding Texas areas. The new Caring Transitions location provides a unique full-service approach that is an end-to-end solution, including decluttering, resettling, clean-outs, space planning, and managing online estate sales providing a win-win experience for everyone.

Key Points: 
  • The latest location, Caring Transitions of Boerne, Fredericksburg and Kerrville, expands the network in the state of Texas.
  • Caring Transitions of Boerne, Fredericksburg and Kerrville is owned and operated by Dershie Kurtz and will look to serve Boerne, Fair Oaks Ranch, Fredericksburg, Kerrville, and the surrounding Texas areas.
  • Dershie credits her love for working with seniors and her relationship with her Mom as part of her inspiration to join Caring Transitions.
  • "We are elated to welcome Dershie to the Caring Transitions franchise family and expand upon our network in the state of Texas," said Ray Fabik, President of Caring Transitions.

Milestone Scientific Commences Sales of CompuFlo®  Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures

Retrieved on: 
星期五, 十二月 8, 2023
Baylor University, MD Anderson Cancer Center, Baylor College of Medicine, Cleveland Clinic, Trauma, Risk, UTHealth School of Dentistry, American Epilepsy Society, Physician, Injection, Electricity, Spinal cord, Hospital, MD, UTMB, Congress, University, Chronic pain, Nursing, Safety, MLSS

ROSELAND, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported it has commenced commercial sales of CompuFlo® disposables for use in neurostimulation spinal cord stimulator implantation procedures at the University of Texas Medical Branch (UTMB) Health Clear Lake Campus Hospital, expanding use of CompuFlo® within the institution beyond the labor and delivery department and training for residents in epidural needle placement and verification.

Key Points: 
  • A spinal cord stimulator is an implanted device that sends low levels of electricity directly into the spinal cord to relieve pain.
  • An estimated 60,000 spinal cord stimulators are implanted each year.
  • Approval and adoption of the technology for neurostimulation spinal cord stimulator implantation follows a successful evaluation process by Dr. Patrick Karas, MD, a full-time faculty neurosurgeon at UTMB, operating at both the Galveston and Clear Lake campuses.
  • Dr. Karas completed 10 cases using the CompuFlo Epidural system, in which he reported 100% success and no complications.

ChemDiv Forges Strategic Partnership with The University of Texas Medical Branch (UTMB) to Expand Its High-throughput Screening Research Capabilities

Retrieved on: 
星期四, 十二月 28, 2023
Research, Research and development, University, Chemical Diversity, UTHealth School of Dentistry, HTS, SAN, UTMB, Pharmaceutical industry

SAN DIEGO, Dec. 28, 2023 /PRNewswire/ -- ChemDiv, a global leader in drug discovery solutions, announces a strategic collaboration with the University of Texas Medical Branch (UTMB) to facilitate the expansion of its inventory and advance the institution's High-throughput Screening (HTS) research programs.

Key Points: 
  • SAN DIEGO, Dec. 28, 2023 /PRNewswire/ -- ChemDiv, a global leader in drug discovery solutions, announces a strategic collaboration with the University of Texas Medical Branch (UTMB) to facilitate the expansion of its inventory and advance the institution's High-throughput Screening (HTS) research programs.
  • ChemDiv's comprehensive suite of fully integrated Research & Development services offers UTMB unparalleled support in its pursuit of groundbreaking medical research.
  • "At ChemDiv, we are dedicated to catalyzing pioneering research, and our collaboration with UTMB exemplifies our commitment to advancing healthcare globally," said Bill Farley, CEO of ChemDiv.
  • "Our team's expertise and cutting-edge resources are poised to significantly augment UTMB's HTS research center, accelerating the discovery of novel therapeutic solutions."

Sila Realty Trust, Inc. Completes Disposition of Webster Healthcare Facility II for $258.4 Million

Retrieved on: 
星期五, 十二月 15, 2023
REIT, Hospitals, Health, Commercial Building & Real Estate, Construction & Property, Sale, Exercise, Bed, UTHealth School of Dentistry, Moses Austin, Regent, University, The Company

Sila Realty Trust, Inc. (the "Company") announced today the disposition of Webster Healthcare Facility II (the “UTMB Health Clear Lake Hospital”) to the Board of Regents of the University of Texas System for a sales price of approximately $258.4 million.

Key Points: 
  • Sila Realty Trust, Inc. (the "Company") announced today the disposition of Webster Healthcare Facility II (the “UTMB Health Clear Lake Hospital”) to the Board of Regents of the University of Texas System for a sales price of approximately $258.4 million.
  • The UTMB Health Clear Lake Hospital, located in Webster, Texas, is an approximately 373,000 square foot short-term acute care hospital with 199 licensed beds.
  • Until the disposition, the facility has been leased to the Board of Regents of the University of Texas and operated as the Clear Lake Campus for the University of Texas Medical Branch.
  • We continue to be steadfast on maximizing the value of the Company and seeking liquidity for our stockholders.”